Burns
Volume 31, Issue 5 , Pages 539-547 , August 2005

Cerium nitrate in the management of burns

  • J.P. Garner

      Affiliations

    • Chesterfield Royal Hospital, Calow, Chesterfield, Derbyshire S44 5BL, UK
    • Corresponding Author InformationCorresponding author. Present address: 6 Kensington Court, Lodge Moor, Sheffield S10 4NL, UK. Tel.: +44 114 230 1237.
    • ,
  • P.S.J. Heppell

      Affiliations

    • The Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK

References 

  1. Arturson G. The Los Alfaques disaster: a boiling liquid, expanding vapour explosion. Burns. 1981;7:233–251
  2. Agee RN, Long JM, Hunt JL, Petroff PA, Lull RJ, Mason AD, et al. Use of 133xenon in early diagnosis of inhalation injury. J Trauma. 1976;16(3):218–224
  3. Hadjiski OG, Lesseva MI. Comparison of four drugs for local treatment of burn wounds. Eur J Emerg Med. 1999;6:41–47
  4. Demling RH. Burns. New Eng J Med. 1985;313:1389–1398
  5. Wassermann D, Sclotterer M, Lebreton F, Levy J, Guelfi MC. Use of topically applied silver sulphadiazine plus cerium nitrate in major burns. Burns. 1989;15:257–260
  6. Koller J, Orsag M. Our experience with the use of cerium sulphadiazine in the treatment of extensive burns. Acta Chirug Plast. 1998;40(3):73–75
  7. Dickinson SJ. Topical therapy of burns in children with silver sulfadiazine. N Y State J Med. 1970;73:2045–2049
  8. Boyce ST, Warden GD. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg. 2002;183:445–456
  9. Ross DA, Phipps AJ, Clarke JA. The use of cerium nitrate–silver sulphadiazine as a topical burns dressing. Br J Plast Surg. 1993;46:582–584
  10. Evans CH. Interesting and useful biochemical properties of lanthanides. Trends Biochem Sci. 1983;445–449
  11. Sipos T, Merkel J. An effect of calcium ions on the activity, heat stability and structure of trypsin. Biochemistry. 1970;9:2766
  12. Gomez J, Birnbaum E, Darnall D. The metal ion acceleration of the conversion of trypsinogen to trypsin (Lanthanide ions as calcium ion substitutes). Biochemistry. 1974;13:3745
  13. Furie BC, Furie B. Interaction of lanthanide ions with bovine factor X and their use in the affinity chromatography of the venom coagulant protein of Vipera russelli. J Biol Chem. 1975;250:601–608
  14. Martin RB, Richardson FS. Lanthanides as probes for calcium in biological systems. Q Rev Biophys. 1979;12:181–209
  15. Bentrop D, Bertini I, Cremonini MA, Forsen S, Luchinat C, Malmendal A. Solution structure of the paramagnetic complex of the N-terminal domain of calmodulin with two cerium ions by 1H-NMR. Biochemistry. 1997;36:11605–11618
  16. Gruner S, Sehrt I, Muller GM, Zwirner A, Strunk D, Sonnichsen N. Inhibition of histamine release from human granulocytes by ions of rare earth elements lanthanum and cerium. Agents Actions. 1992;36:207–211
  17. Gruner S, Diezel W, Strunk D, Eckert R, Siems W, Anhalt GJ. Inhibition of Langerhans cell ATPase and contact sensitization by lanthanides—role of T suppressor cells. J Invest Dermatol. 1991;97:478–482
  18. Buchanan RE, Fulmer EI. Physiology and biochemistry of bacteria (II. Effects of environment upon microorganisms). Baltimore: Williams & Wilkins; 1930;
  19. Burkes S, McCleskey CS. The bacteriostatic activity of cerium, lanthanum and thallium. J Bacteriol. 1947;54:417–424
  20. Sobek JM, Talburt DE. The effects of rare earth cerium on Escherichia coli. J Bacteriol. 1968;95:47–51
  21. Talburt DE, Johnson GT. Some effects of rare earth elements and ytrrium on microbial growth. Mycologia. 1967;59:492–503
  22. Fox CL. Silver sulfadiazine: a new topical therapy for pseudomonas in burns. Arch Surg. 1968;96:184–188
  23. Fox CL. Pharmacology and clinical use of silver sulphadiazine and related topical antimicrobial agents. Pahlavi Med J. 1977;8:45–64
  24. Monafo WW, Tandon SN, Ayvazian VH, Tuchsmidt J, Skinner AM, Deitz F. Cerium nitrate: a new topical antiseptic for extensive burns. Surgery. 1976;80(4):465–473
  25. Bull JP. Revised analysis of mortality due to burns. Lancet. 1971;2(7734):1133–1134
  26. Saffer LD, Rodeheaver GT, Hiebert JM, Edlich RF. In vivo and in vitro antimicrobial activity of silver sulfadiazine and cerium nitrate. Surg Gynaecol Obstet. 1980;151:232–236
  27. Holder IA. In vitro inactivation of silver sulphadiazine by the addition of cerium salts. Burns. 1982;8:274–277
  28. Rosenkranz HS. A synergistic effect between cerium nitrate and silver sulphadiazine. Burns. 1979;5:278–281
  29. Carr HS, Wlodkowski TJ, Rosenkranz HS. Silver sulfadiazine: in vitro antibacterial activity. Antimicrob Agents Chemother. 1973;4:585
  30. Rosenkranz HS, Carr HS. The determination of the susceptibility of bacterial isolates to silver sulfadiazine. Chemotherapy. 1978;24:143–145
  31. Bowser BH, Caldwell FT, Cone JB, Eisenach KD, Thompson CH. A prospective analysis of silver sulfadiazine with and without cerium nitrate as a topical agent in the treatment of severely burned children. J Trauma. 1981;21(7):558–563
  32. Monafo WW, Robinson HN. The treatment of burned children. Clin Plast Surg. 1977;4(4):537–546
  33. Marone P, Monzillo V, Perversi L, Carretto E. Comparative in vitro activity of silver sulfadiazine, alone and in combination with cerium nitrate against staphylococci and Gram-negative bacteria. J Chemother. 1998;10(1):17–21
  34. Nagesha CN, Shenoy KJ, Chandreshekar MR. Study of burn sepsis with special reference to Pseudomonas aeruginosa. J Indian Med Assoc. 1996;94:230–233
  35. Heruzo-Cabrera R, Garcia-Torres V, Rey-Calero J, Vizcaino-Alcaide MJ. Evaluation of the penetration strength, bactericidal efficacy and spectrum of action of several antibacterial creams against micro-organisms in a burn centre. Burns. 1992;18:39–44
  36. Tompkins RG, Burke JF, Schoenfeld DA, Bondoc CC, Quinby WC, et al. Prompt eschar excision: a treatment system contributing to reduced burn mortality. Ann Surg. 1986;204:272–281
  37. Allgower M, Burri C, Gruber UL, Nagel G. Toxicity of burned mouse skin in relation to burn temperature. Surg Forum. 1963;14:37
  38. Schoenenberger GA. Burn toxins isolated from mouse and human skin. Monogr Allergy. 1975;9:72
  39. Antonacci AC, Good RA, Gupta S. T cell subpopulations following thermal injury. Surg Gynaecol Obstet. 1982;155:1–8
  40. Zapata-Sirvent RL, Hansborough JF. Postburn immunosuppression in an animal model (III. Maintenance of splenic helper and suppressor lymphocyte sub-populations by immunomodulating drugs). Surgery. 1985;97(6):721–727
  41. Zapata-Sirvent RL, Hansborough JF, Bender EM, Bartle EJ, Mansour MA, Carter WH. Postburn immunosuppression in an animal model (IV. Improved resistance to septic challenge with immunomodulating drugs). Surgery. 1986;99:53–59
  42. Peterson VM, Hansbrough JF, Wang XW, Zapata-Sirvent , Boswick JA. Topical cerium nitrate prevents postburn immunosuppression. J Trauma. 1985;25(11):1039–1044
  43. Hansbrough JF, Peterson V, Kortz E, Piacentine JG. Studies of postburn immunosuppression using an animal model: monocyte dysfunction induced by burn tissue. Surgery. 1983;93:415–423
  44. Struzyna J, Pojda Z, Braun B, Chomicka M, Sobiczewska , Wrembel J. Serum cytokine levels (IL-4, IL-6, IL-8, G-CSF, GM-CSF) in burned patients. Burns. 1995;21(6):437–440
  45. Sparkes BG. Immunological responses to thermal injury. Burns. 1997;23(2):106–113
  46. Sparkes BG. Mechanisms of immune failure in burn injury. Vaccine. 1993;11:504–509
  47. Deveci M, Eski M, Sengezer M, Kisa U. Effects of cerium nitrate bathing and prompt burn wound excision on IL-6 and TNF alpha levels in burned rats. Burns. 2000;26:41–45
  48. Sengezer M, Deved M, Eski M. Cerium nitrate bathing prevents TNF-α elevation following burn injury (experimental study). Ann Medit Burns Club. 1998;11(4):227–231
  49. Eski M, Devici M, Celikoz B, Nisanci M, Turegan M. Treatment with cerium nitrate bathing modulates systemic leukocyte activity following burn injury: an experimental study in rat cremaster muscle flap. Burns. 2001;27:739–746
  50. Kistler D, Hafemann B, Schoeneneberger GA, Hettich R. Increased survival rates by topical treatment of burns with cerium nitrate. Eur Surg Res. 1990;22:283–290
  51. Scheidegger D, Sparkes BG, Luscher N, Schoeneneberger GA, Allgöwer M. Survival in major burn injuries treated by one bathing in cerium nitrate. Burns. 1992;18(4):296–300
  52. Allgöwer M, Schoenenberger GA, Sparkes BG. Burning the largest immune organ. Burns. 1995;21(Suppl. 1):S7–S47
  53. Boeckx W, Blondeel PhN, Vandersteen K, De Wolf-Peeters C, Schmitz A. Effect of cerium nitrate–silver sulphadiazine on deep dermal burns: a histological hypothesis. Burns. 1992;18(6):456–462
  54. Kremer B, Allgöwer M, Graf M, Schmidt KH, Schoelmerich J, Schoeneneberger GA. The present status of research in burn toxins. Intensive Care Med. 1981;7:77–87
  55. Fox CL, Monafo WW, Ayvazian VH, Skinner AM, Modak S, Stanford J, et al. Topical chemotherapy for burns using cerium salts and silver sulfadiazine. Surg Gynaecol Obstet. 1977;144:668–672
  56. Monafo L. The use of topical cerium nitrate–silver sulfadiazine in major burn injuries. Pan Med. 1983;25:151–154
  57. Munster AM, Helvig EI, Rowland S. Cerium nitrate–silver sulphadiazine cream in the treatment of burns: a prospective evaluation. Surgery. 1980;88(5):658–660
  58. de Gracia CG. An open study comparing topical silver sulfadiazine and topical silver sulfadiazine–cerium nitrate in the treatment of moderate and severe burns. Burns. 2001;27:67–74
  59. Winter GD. Formation of the scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig. Nature. 1962;193:283–294
  60. Bruce DW, Heitbank BE, DuBois KP. The acute mammalian toxicity of rare earth nitrates and oxides. Toxicol Appl Pharmacol. 1963;5:750–759
  61. Hayley TJ. Pharmacology and toxicology of the rare earth elements. J Pharm Sci. 1965;54:663
  62. Hirakawa K. Determination of silver and cerium in the liver and the kidney from a severely burned infant treated with silver sulfadiazine and cerium nitrate. Radioisotopes. 1983;32:59–65
  63. Ternberg JL, Luce E. Methemoglobinemia: a complication of silver nitrate treatment of burns. Surgery. 1968;63:328
  64. Lister S. Center speeds approval of emergency IND, 2 supplements. http://www.fda.gov/cder/pike/septoct2001.htm.
  65. Abdalla S, Dadalti P. Silver sulphadiazine and cerium nitrate in venous ulcers: two case reports. An Bras Dermatol. 2003;78(2):227–233
  66. Garner JP, Heppell PSJ. The use of Flammacerium in British Burns units. Burns. 2005;31(3):379–382

PII: S0305-4179(05)00029-X

doi: 10.1016/j.burns.2005.01.014

Burns
Volume 31, Issue 5 , Pages 539-547 , August 2005

Article Tools